This study aims to clarify if a tetracycline antibiotic (minocycline) can help the heart and blood vessels in patients with diabetes and who have high levels of a blood protein called Matrix Metalloproteinase-9 (MMP-9).
- Registry ID
- EUCTR2015-002387-16
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Solvotrin Innovations Ltd
- Start date
- 2015-07-31
- Completion date
- 2017-04-10
- Last update
- 2026-08-16
Conditions
- Type II diabetes mellitus
Summary
To investigate the impact of one year therapy with minocycline on MMP-9 in patients with with Type 2 diabetes and the MMP-9, 1562 C>T promoter single nucleotide polymorphism
Locations
View on source registry